Navigation Links
Johnson & Johnson Completes Acquisition of Cougar Biotechnology
Date:7/10/2009

a meaningful difference in the lives of millions of patients worldwide," said William N. Hait, M.D., Ph.D., Global Therapeutic Head, Oncology, Ortho Biotech Oncology Research & Development. "Abiraterone acetate now becomes one of many new treatments we are developing, which we hope will change the course of cancer treatment by targeting cancer cells and the tumor microenvironment."

About Johnson & Johnson

Caring for the world, one person at a time ... inspires and unites the people of Johnson & Johnson. We embrace research and science -- bringing innovative ideas, products and services to advance the health and well-being of people. Our 119,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Additional Information

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Johnson & Johnson's expectations and projections. Risks and uncertainties include: general industry conditions and competition; business and economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 28, 2008. Copies of these filings, as well as s
'/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
2. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
3. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
4. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
5. Johnson & Johnson Announces Changes to Accelerate Growth
6. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
7. Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life
8. MultiVu Video Feed: Johnson & Johnson Diabetes Institute, LLC Launches New Training Center to Improve Community-Based Diabetes Care
9. Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
10. Craig Johnson Joins Ardea Biosciences Board of Directors
11. Migenix averts proxy contest; reaches agreement with DJohnson holdings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... LONDON and BOSTON , June ... market is set to reach $127 billion by 2018, accounting ... to the recently released Orphan Drug Report 2013 ... its clients, needs in regard to this growing segment of ... core product database to include in-depth, fact-based orphan drug analysis ...
(Date:6/17/2013)... June 17, 2013 With the huge success ... of the Chief Medical Officer Summit for Emerging Life Science ... take place in San Francisco on November 4-5, 2013 at ... first time, West Coast Chief Medical Officers at biotechs have ... Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive Director ...
(Date:6/17/2013)... MUNDELEIN, Ill. , June 17, 2013 /PRNewswire/ ... – News), a biotechnology company providing value-added ingredients ... it will be presenting a new meat application ... (IFT) show in Chicago , ... Trim ingredients can replace more expensive/chemically-modified ingredients in ...
(Date:6/17/2013)... DUBLIN , June 17, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/9rwvs2/north_america ) has announced the addition of ... Market - by Formulations [Liposomes, Microspheres, & ... Prefilled, Pen, Needle Free & Auto Injectors] ... to their offering. ,      ...
Breaking Biology Technology:Evaluate Launches Enhanced Orphan Drug Intelligence 2Evaluate Launches Enhanced Orphan Drug Intelligence 3Chief Medical Officer Summit for Biotechs Goes West 2Chief Medical Officer Summit for Biotechs Goes West 3Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 2Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 3North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 2North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 3
... N.J., Dec. 17 National Stem,Cell Holding, Inc. ... financial information, quotations and press releases are,posted on ... OTCIQ is a secure, web-based portal that ... facilitate communication with the,marketplace, promote transparency, mitigate risk, ...
... Genzyme Corp.,(Nasdaq: GENZ ) announced today that ... a supplemental indication for Thyrogen(R) (thyrotropin,alfa for injection) ... ablate,or destroy, the remaining thyroid tissue in patients ... is a procedure that patients,commonly undergo when being ...
... DIEGO, Dec. 17 SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ... appointed to,the company,s Board of Directors. Mr. Turner brings ... and will also serve on,the company,s audit committee., ... said Dr. Christopher S.,Henney, Chairman of the Board of ...
Cached Biology Technology:National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC 2Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation 2Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation 3Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation 4SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors 2SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors 3
(Date:6/14/2013)... Cliffs of Dover" was a morale-boosting song that lifted ... mark the point at which England is closest to ... structures made of the chalky, white shells that envelop ... . "Ehux" is a coccolithophore, with an exoskeleton made ... the alga,s "armor" forms releases carbon dioxide, Ehux can ...
(Date:6/14/2013)... 12 June 2013: Data presented at EULAR 2013, the ... that novel antibody biomarkers could significantly improve diagnosis in ... UH-RA.1, UH-RA.9, UH-RA.14 and UH-RA.21 were investigated; as ... were present in both early and seronegative disease, ... and ACCP -negative patients testing positive. , RA ...
(Date:6/13/2013)... that combining improved oyster restoration methods with limits on ... population back to the Bay in a much shorter ... of the University of Maryland Center for Environmental Science,s ... restoration options to see which ones would have the ... we developed suggests that oysters should be able to ...
Breaking Biology News(10 mins):Chalking up a marine blooming alga: Genome fills a gap in the tree of life 2Chalking up a marine blooming alga: Genome fills a gap in the tree of life 3Chalking up a marine blooming alga: Genome fills a gap in the tree of life 4Oysters could rebound more quickly with limited fishing and improved habitat 2
... remains the subject of "best guesses," and as a ... perceptions and politics, rather than an objective assessment of ... , Simon Hay and Robert Snow (Kenya Medical Research ... been almost 40 years since the last global map ...
... be arranged along a ladder of intelligence—a sort of ... by our close relatives, the primates, all the way ... past decade, this ladder has been challenged by claims ... animals. For example, spotted hyenas establish hierarchies in which ...
... fight viruses is also involved in keeping cancer cells alive, ... The anti-viral molecule, called TBK-1, was found to be essential ... to a treatment for fighting cancer, the researchers report in ... surprise that this mechanism is involved in cancer cell survival, ...
Cached Biology News:Fishy cooperation 2Natural anti-viral enzyme helps keep cancer cells alive, researchers find 2
... IgY Antibodies Hypothetical protein FLJ20644, likely ... Protein Accession #: NP_060387.1 ... Genbank Definition: chromosome 14 open ... phosphatase subunit gene g4-1 [Homo sapiens] ...
Request Info...
Lineage cocktail 1 (lin 1) 50 tests...
Contained in EZ-Tn5™ Kits and are available separately for sequencing of an insertion site....
Biology Products: